Assessment for Nasal Glucagon Medication Administration (Baqsimi) is a legal document that was released by the Wisconsin Department of Public Instruction - a government authority operating within Wisconsin.
Q: What is Nasal Glucagon Medication (Baqsimi)?
A: Nasal Glucagon Medication (Baqsimi) is a medication used to treat severe low blood sugar in adults and children with diabetes.
Q: How is Nasal Glucagon Medication (Baqsimi) administered?
A: Nasal Glucagon Medication (Baqsimi) is administered through the nose as a nasal spray.
Q: Who can administer Nasal Glucagon Medication (Baqsimi)?
A: Nasal Glucagon Medication (Baqsimi) can be administered by anyone, even without medical training, in an emergency situation.
Q: Is a prescription required for Nasal Glucagon Medication (Baqsimi)?
A: Yes, a prescription is required to obtain Nasal Glucagon Medication (Baqsimi).
Q: What are the side effects of Nasal Glucagon Medication (Baqsimi)?
A: Common side effects of Nasal Glucagon Medication (Baqsimi) may include nausea, vomiting, headache, and nasal congestion.
Q: How should Nasal Glucagon Medication (Baqsimi) be stored?
A: Nasal Glucagon Medication (Baqsimi) should be stored at room temperature between 68°F to 77°F (20°C to 25°C).
Q: Is Nasal Glucagon Medication (Baqsimi) covered by insurance?
A: Insurance coverage for Nasal Glucagon Medication (Baqsimi) varies, so it's best to check with your insurance provider.
Q: Can Nasal Glucagon Medication (Baqsimi) be used for children?
A: Yes, Nasal Glucagon Medication (Baqsimi) is approved for use in children aged 4 years and older.
Form Details:
Download a printable version of the form by clicking the link below or browse more documents and templates provided by the Wisconsin Department of Public Instruction.